+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

High-dose steroids as a therapeutic option in the management of spur cell haemolytic anaemia

High-dose steroids as a therapeutic option in the management of spur cell haemolytic anaemia

BMJ Case Reports 2018

Spur cell haemolytic anaemia (SCA) is a form of anaemia that can be seen in patients with severely impaired liver function or advanced cirrhosis. It is associated with high mortality. The treatment options for SCA secondary to cirrhosis are limited. Our patient is a middle-aged man who developed SCA and was not a candidate for liver transplantation or splenectomy. High-dose steroids helped ameliorate haemolysis and improve anaemia and general condition of our patient.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 065192534

Download citation: RISBibTeXText

PMID: 29386216

Related references

Giant cell hepatitis with Coombs-positive haemolytic anaemia: steroid sparing with high-dose intravenous immunoglobulin and cyclosporine. Acta Paediatrica 102(3): E137-E139, 2013

Nitrofurazone-induced haemolytic anaemia in a refractory case of Trypanosoma rhodesiense sleeping sickness: the haemolytic trait and self-limiting haemolytic anaemia. Annals of Tropical Medicine and Parasitology 55: 49-63, 1961

High-dose intravenous immunoglobulin in the treatment of autoimmune haemolytic anaemia. Clinical and Laboratory Haematology 10(4): 391-395, 1988

Pulsed high-dose dexamethasone in chronic autoimmune haemolytic anaemia of warm type. British Journal of Haematology 98(4): 860-862, 1997

Therapeutic management and the effect of splenectomy in patients with haemolytic anaemia due to intracardiac valvular prosthesis and associated haemoglobinopathy. Haematologica 60(1): 62-72, 1975

Immunoglobulin high-dose therapy: RBC-alloantibodies in commercial preparations and haemolytic anaemia: a case report. Beitrage Zur Infusionstherapie und Transfusionsmedizin 32: 474-475, 1994

Haemolytic anaemia associated with high dose intravenous immunoglobulin therapy in a child with Guillain-Barre syndrome. Archives of Disease in Childhood 88(9): 836-B-837, 2003

Cutaneous Alternaria infectoria infection in a dog in association with therapeutic immunosuppression for the management of immune-mediated haemolytic anaemia. Veterinary Dermatology 21(6): 626-634, 2011

Unexplained haemolytic anaemia in successive pregnancies with negative direct antiglobulin test and response to high dose i.v. IgG. British Journal of Obstetrics and Gynaecology 101(1): 75-77, 1994

Clinical results in 2001 show high dose therapy and hematopoietic progenitor cell transplantation as a therapeutic option for breast cancer. Haematologica 86(9): 900-907, 2001

Successful management of concurrent congenital dyserythropoietic anaemia and autoimmune haemolytic anaemia with splenectomy. British Journal of Haematology 102(5): 1182-1186, Sept, 1998

Severe anaemia caused by Human Parvovirus B19 infection in a patient with autoimmune haemolytic anaemia and a B-cell non-Hodgkin lymphoma. Nederlands Tijdschrift Voor Geneeskunde 152(3): 153-157, 2008

Hereditary haemolytic anaemia, sickle cell anaemia. Radiography 45(537): 191-195, 1979

Comparison of high dose inhaled steroids, low dose inhaled steroids plus low dose theophylline, and low dose inhaled steroids alone in chronic asthma in general practice. Thorax 55(10): 837-841, 2000

Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?. Biology of Blood and Marrow Transplantation 12(10): 1085-1091, 2006